Health Catalyst to Participate in Upcoming Investor Conference
December 10 2024 - 7:05AM
Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading
provider of data and analytics technology and services to
healthcare organizations, today announced that Dan Burton, Chief
Executive Officer, Jason Alger, Chief Financial Officer, Dan
LeSueur, Chief Operating Officer, and Jack Knight, Vice President
of Investor Relations, will participate in the 43rd Annual J.P.
Morgan Healthcare Conference in San Francisco, including a
presentation on Wednesday, January 15, 2025, at 10:30 am PT. The
webcast link and related presentation materials will be available
online at https://ir.healthcatalyst.com.
About Health Catalyst
Health Catalyst is a leading provider of data and analytics
technology and services to healthcare organizations and is
committed to being the catalyst for massive, measurable,
data-informed healthcare improvement. Its clients leverage the
cloud-based data platform—powered by data from more than 100
million patient records and encompassing trillions of facts—as well
as its analytics software and professional services expertise to
make data-informed decisions and realize measurable clinical,
financial, and operational improvements. Health Catalyst envisions
a future in which all healthcare decisions are data informed.
Health Catalyst Investor Relations Contact:
Jack KnightVice President, Investor Relations+1 (855)
309-6800ir@healthcatalyst.com
Health Catalyst Media Contact:
Amanda FlandersSenior Vice President, Marketing and
Communicationsmedia@healthcatalyst.com
Health Catalyst (NASDAQ:HCAT)
Historical Stock Chart
From Dec 2024 to Jan 2025
Health Catalyst (NASDAQ:HCAT)
Historical Stock Chart
From Jan 2024 to Jan 2025